Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass

Journal of Thoracic and Cardiovascular Surgery

Volumn 130, Issue 1, 2005, Pages 107-113

  Avidan, M S ^a   Levy, J H ^b   Van Aken, H ^c   Feneck, R O ^d   Latimer, R D ^e   Ott, E ^f   Martin, E ^g   Birnbaum, D E ^h   Bonfiglio, L J ⁱ   Kajdasz, D K ^j   Despotis, G J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e PAPWORTH HOSPITAL   (United Kingdom)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h UNIVERSITY HOSPITAL REGENSBURG   (Germany)

ⁱ GTC Biotherapeutics Inc   (United States)

^j ELI LILLY AND COMPANY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; FRESH FROZEN PLASMA; HEPARIN; PLACEBO; RECOMBINANT HUMAN ANTITHROMBIN III; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; ELECTIVE SURGERY; HEART SURGERY; HEMOSTASIS; HOSPITALIZATION; HUMAN; INCIDENCE; MULTICENTER STUDY; PATIENT MONITORING; PLASMA TRANSFUSION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT FAILURE; TUBE;

ADULT; AGED; ANTITHROMBIN III; BLOOD COAGULATION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FIBRINOLYTIC AGENTS; HEMOSTASIS, SURGICAL; HEPARIN; HUMANS; MIDDLE AGED; PEPTIDE HYDROLASES; RECOMBINANT PROTEINS; WHOLE BLOOD COAGULATION TIME;

EID: 21744444282     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.10.045     Document Type: Article

References (21)

1. J.A. Young, C.T. Kisker, D.B. Doty Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer Ann Thorac Surg 26 1978 231 240
2. G.J. Despotis, G. Gravlee, K. Filos, J. Levy Anticoagulation monitoring during cardiac surgery a review of current and emerging techniques Anesthesiology 91 1999 1122 1151
3. R.A. Esposito, A.T. Culliford, S.B. Colvin, S.J. Thomas, H. Lackner, F.C. Spencer Heparin resistance during cardiopulmonary bypass The role of heparin pretreatment J Thorac Cardiovasc Surg 85 1983 346 353
4. E.F. Anderson Heparin resistance prior to cardiopulmonary bypass Anesthesiology 64 1986 504 507
5. G.J. Despotis, V. Levine, J.H. Joist, D. Joiner-Maier, E. Spitznagel Antithrombin III during cardiac surgery effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation Anesth Analg 85 1997 498 506
6. J.H. Lemmer Jr, G.J. Despotis Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery J Thorac Cardiovasc Surg 123 2002 213 217
7. J.H. Levy, G.J. Despotis, F. Szlam, P. Olson, D. Meeker, A. Weisinger Recombinant human transgenic antithrombin in cardiac surgery a dose-finding study Anesthesiology 96 2002 1095 1102
8. A.H. Sabbagh, G.K. Chung, P. Shuttleworth, B.J. Applegate, W. Gabrhel Fresh frozen plasma a solution to heparin resistance during cardiopulmonary bypass Ann Thorac Surg 37 1984 466 468
9. J.N. Shanberge, T.M. Quattrociocchi-Longe, M.H. Martens Interrelationship of protamine and platelet factor 4 in the neutralization of heparin Thromb Res 46 1987 89 100
10. A. Vuylsteke, R.J. Mills, A.E. Crosbie, T.I. Burns, R.D. Latimer Increased pre-operative platelet counts are a possible predictor for reduced sensitivity to heparin Br J Anaesth 85 2000 896 898
11. J. Hirsh, S.S. Anand, J.L. Halperin, V. Fuster Guide to anticoagulant therapy: Heparin: a statement for healthcare professionals from the American Heart Association Circulation 103 2001 2994 3018
12. K.H. Teoh, E. Young, C.A. Bradley, J. Hirsh Heparin binding proteins Contribution to heparin rebound after cardiopulmonary bypass Circulation 88 suppl II 1993 II420 II425
13. E.C. Consten, C.P. Henny, L. Eijsman, D.A. Dongelmans, M.H. van Oers The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified J Thorac Cardiovasc Surg 112 1996 162 167
14. R.L. Reed 2nd, D. Ciavarella, D.M. Heimbach, L. Baron, E. Pavlin, R.B. Counts Prophylactic platelet administration during massive transfusion A prospective, randomized, double-blind clinical study Ann Surg 203 1986 40 48
15. M.P. Fanashawe, L. Shore-Lesserson, D.L. Reich Two cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest Anesthesiology 95 2001 1525 1527
16. D.A. Stump, A.T. Rogers, J.W. Hammon, S.P. Newman Cerebral emboli and cognitive outcome after cardiac surgery J Cardiothorac Vasc Anesth 10 1996 113 119
17. P.G. Loubser, J.J. McCarthy, M. Attar Coronary thrombosis associated with antithrombin-III deficiency J Cardiothorac Vasc Anesth 11 1997 756 759
18. A.T. Cheung, S.K. Levin, S.J. Weiss, M.A. Acker, N. Stenach Intracardiac thrombus a risk of incomplete anticoagulation for cardiac operations Ann Thorac Surg 58 1994 541 542
19. G.J. Despotis, J.H. Joist, C.W. Hogue Jr, A. Alsoufiev, K. Kater, L.T. Goodnough The impact of heparin concentration and activated clotting time monitoring on blood conservation a prospective, randomized evaluation in patients undergoing cardiac operation J Thorac Cardiovasc Surg 110 1995 46 54
20. G.J. Despotis, J.H. Joist, C.W. Hogue Jr, A. Alsoufiev, D. Joiner-Maier, S.A. Santoro More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT Thromb Haemost 76 1996 902 908
21. M.S. Avidan, J.H. Levy, J. Scholz, E. Delphin, P.M. Rosseel, M.B. Howie A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass Anesthesiology 102 2005 276 284